Literature DB >> 18049116

Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies.

Daniel Skuk1, Martin Paradis, Marlyne Goulet, Jacques P Tremblay.   

Abstract

BACKGROUND: Several cell-transplantation strategies implicate the injection of cells into tissues. Avascular accumulations of implanted cells are then formed. Because the diffusion of oxygen and nutrients from the surrounding tissue throughout the implanted cell accumulations may be limited, central ischemic necrosis could develop. We analyzed this possibility after myoblast transplantation in nonhuman primates.
METHODS: Macaca monkeys were injected intramuscularly with different amounts of myoblasts per single site. These sites were sampled 1 hr later and at posttransplantation days 1, 3, 5, and 7 and analyzed by histological techniques.
RESULTS: One day posttransplantation, the largest pockets of implanted cells showed cores of massive necrosis. The width of the peripheral layer of living cells was approximately 100-200 microm. We thus analyzed the relationship between the amount of myoblasts injected per site and the volume of ischemic necrosis. Delivering 0.1 x 10(6) and 0.3 x 10(6) myoblasts did not produce ischemic necrosis; pockets of 1 x 10(6), 3 x 10(6), 10 x 10(6), and 20 x 10(6) myoblasts exhibited, respectively, a mean of 2%, 9%, 41%, and 59% of central necrosis. Intense macrophage infiltration took place in the muscle, invading the accumulations of necrotic cells and eliminating them by posttransplantation days 5 to 7.
CONCLUSIONS: The desire to create more neoformed tissue by delivering more cells per injection site is confronted with the fact that the acute survival of the implanted cells is restricted to the peripheral layer that can profit of the diffusion of oxygen and nutriments from the surrounding recipient's tissue.

Entities:  

Mesh:

Year:  2007        PMID: 18049116     DOI: 10.1097/01.tp.0000288322.94252.22

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  19 in total

Review 1.  Cell delivery: from cell transplantation to organ engineering.

Authors:  Alejandro Soto-Gutierrez; Hiroshi Yagi; Basak E Uygun; Nalu Navarro-Alvarez; Korkut Uygun; Naoya Kobayashi; Yong-Guang Yang; Martin L Yarmush
Journal:  Cell Transplant       Date:  2010-06-03       Impact factor: 4.064

Review 2.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

3.  Radially branched deployment for more efficient cell transplantation at the scale of the human brain.

Authors:  Matthew T Silvestrini; Dali Yin; Valerie G Coppes; Preeti Mann; Alastair J Martin; Paul S Larson; Philip A Starr; Nalin Gupta; S Scott Panter; Tejal A Desai; Daniel A Lim
Journal:  Stereotact Funct Neurosurg       Date:  2013-01-22       Impact factor: 1.875

4.  Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal Muscle.

Authors:  Lindsey A Muir; Charles E Murry; Jeffrey S Chamberlain
Journal:  Stem Cells Dev       Date:  2016-09-07       Impact factor: 3.272

5.  Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy.

Authors:  Jane T Seto; Niclas E Bengtsson; Jeffrey S Chamberlain
Journal:  Curr Pediatr Rep       Date:  2014-06-01

Review 6.  Emerging strategies for cell and gene therapy of the muscular dystrophies.

Authors:  Lindsey A Muir; Jeffrey S Chamberlain
Journal:  Expert Rev Mol Med       Date:  2009-06-25       Impact factor: 5.600

7.  Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies.

Authors:  Matthew B Potts; Matthew T Silvestrini; Daniel A Lim
Journal:  Surg Neurol Int       Date:  2013-03-19

8.  Murine and human myogenic cells identified by elevated aldehyde dehydrogenase activity: implications for muscle regeneration and repair.

Authors:  Joseph B Vella; Seth D Thompson; Mark J Bucsek; Minjung Song; Johnny Huard
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

9.  3D timelapse analysis of muscle satellite cell motility.

Authors:  Ashley L Siegel; Kevin Atchison; Kevin E Fisher; George E Davis; D D W Cornelison
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

Review 10.  The emerging biology of muscle stem cells: implications for cell-based therapies.

Authors:  C Florian Bentzinger; Yu Xin Wang; Julia von Maltzahn; Michael A Rudnicki
Journal:  Bioessays       Date:  2012-08-06       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.